Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH3 MYO1A MYO5B MYO7A DNAH14 DNAH10 DYNC2H1 DNAH11	1.87e-05	118	192	8	GO:0003774
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DNAH10 DYNC2H1 DNAH11	2.28e-05	18	192	4	GO:0008569
GeneOntologyMolecularFunction	G-protein beta/gamma-subunit complex binding	GNAL GNAT2 GNA14 GNAT3	8.95e-05	25	192	4	GO:0031683
GeneOntologyMolecularFunction	recombination hotspot binding	PRDM9 PRDM7	9.20e-05	2	192	2	GO:0010844
GeneOntologyMolecularFunction	neurohypophyseal hormone activity	AVP OXT	9.20e-05	2	192	2	GO:0005185
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DNAH10 DYNC2H1 DNAH11	1.42e-04	28	192	4	GO:0051959
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	MECOM PRDM9 SETDB2	2.33e-04	13	192	3	GO:0046974
GeneOntologyMolecularFunction	V1A vasopressin receptor binding	AVP OXT	2.74e-04	3	192	2	GO:0031894
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH14 DNAH10 DYNC2H1 DNAH11	4.27e-04	37	192	4	GO:0045505
GeneOntologyMolecularFunction	microfilament motor activity	MYH3 MYO1A MYO5B MYO7A	4.74e-04	38	192	4	GO:0000146
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MYH3 MYO5B AK6 MCM6 RND1 ATP11C GNAL GNAT2 DNAH10 DYNC2H1 ABCF2 DHX30 ORC1 GNA14 DNM3 CCT6B GNAT3 DNAH11	5.10e-04	775	192	18	GO:0017111
GeneOntologyMolecularFunction	vasopressin receptor binding	AVP OXT	5.45e-04	4	192	2	GO:0031893
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	MECOM PRDM9 PRDM7 SETDB2	8.33e-04	44	192	4	GO:0140938
GeneOntologyMolecularFunction	ATP-dependent activity	MYH3 MYO1A MYO5B MYO7A AK6 MCM6 DNAH14 ATP11C DNAH10 DYNC2H1 ABCF2 DHX30 ORC1 CCT6B DNAH11	9.08e-04	614	192	15	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH3 MYO5B AK6 MCM6 ATP11C DNAH10 DYNC2H1 ABCF2 DHX30 ORC1 CCT6B DNAH11	1.20e-03	441	192	12	GO:0016887
GeneOntologyMolecularFunction	pyrophosphatase activity	MYH3 MYO5B AK6 MCM6 RND1 ATP11C GNAL GNAT2 DNAH10 DYNC2H1 ABCF2 DHX30 ORC1 GNA14 DNM3 CCT6B GNAT3 DNAH11	1.26e-03	839	192	18	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	MYH3 MYO5B AK6 MCM6 RND1 ATP11C GNAL GNAT2 DNAH10 DYNC2H1 ABCF2 DHX30 ORC1 GNA14 DNM3 CCT6B GNAT3 DNAH11	1.28e-03	840	192	18	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	MYH3 MYO5B AK6 MCM6 RND1 ATP11C GNAL GNAT2 DNAH10 DYNC2H1 ABCF2 DHX30 ORC1 GNA14 DNM3 CCT6B GNAT3 DNAH11	1.28e-03	840	192	18	GO:0016818
GeneOntologyMolecularFunction	actin filament binding	MYH3 ABI3 MYO1A MYO5B MYO7A AIF1L IQGAP1 CYFIP1	1.63e-03	227	192	8	GO:0051015
GeneOntologyCellularComponent	SCAR complex	ABI3 CYFIP1 CYFIP2	1.51e-04	12	189	3	GO:0031209
GeneOntologyCellularComponent	myosin complex	MYH3 MYO1A MYO5B MYO7A CGNL1	1.93e-04	59	189	5	GO:0016459
GeneOntologyCellularComponent	heterotrimeric G-protein complex	GNAL GNAT2 GNA14 GNAT3	2.72e-04	35	189	4	GO:0005834
GeneOntologyCellularComponent	vesicle tethering complex	COG3 COG5 NBAS EXOC5 TNFAIP2	4.91e-04	72	189	5	GO:0099023
GeneOntologyCellularComponent	GTPase complex	GNAL GNAT2 GNA14 GNAT3	5.05e-04	41	189	4	GO:1905360
GeneOntologyCellularComponent	cell cortex	MYO1A MYO5B MYO7A BFSP1 IQGAP1 PTK2B FGF1 NOS2 CAPN2 EXOC5 TNFAIP2	5.84e-04	371	189	11	GO:0005938
GeneOntologyCellularComponent	photoreceptor inner segment	MYO7A GNAT2 KIFAP3 DNM3 GNAT3	7.09e-04	78	189	5	GO:0001917
Domain	P-loop_NTPase	ADCY10 MYH3 NLRP12 MYO1A MYO5B MYO7A AK6 MCM6 NDUFA10 DNAH14 IQGAP1 TRANK1 RND1 GNAL GNAT2 GNL3L DNAH10 DYNC2H1 IFI44 ABCF2 DHX30 NLRP6 ORC1 GNA14 DNM3 GNAT3 DNAH11	1.75e-07	848	192	27	IPR027417
Domain	IQ	MYH3 MYO1A MYO5B MYO7A OBSCN IQGAP1 RNF32	8.30e-06	71	192	7	PF00612
Domain	-	ADCY10 NLRP12 MYO7A AK6 MCM6 NDUFA10 DNAH14 TRANK1 RND1 GNAL GNAT2 GNL3L DNAH10 DYNC2H1 IFI44 ABCF2 DHX30 ORC1 GNA14 DNM3 GNAT3 DNAH11	9.03e-06	746	192	22	3.40.50.300
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH10 DYNC2H1 DNAH11	1.00e-05	14	192	4	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DNAH10 DYNC2H1 DNAH11	1.00e-05	14	192	4	IPR024743
Domain	MT	DNAH14 DNAH10 DYNC2H1 DNAH11	1.00e-05	14	192	4	PF12777
Domain	AAA_8	DNAH14 DNAH10 DYNC2H1 DNAH11	1.00e-05	14	192	4	PF12780
Domain	DHC_fam	DNAH14 DNAH10 DYNC2H1 DNAH11	1.35e-05	15	192	4	IPR026983
Domain	Dynein_heavy	DNAH14 DNAH10 DYNC2H1 DNAH11	1.35e-05	15	192	4	PF03028
Domain	Dynein_heavy_dom	DNAH14 DNAH10 DYNC2H1 DNAH11	1.35e-05	15	192	4	IPR004273
Domain	GproteinA_insert	GNAL GNAT2 GNA14 GNAT3	1.79e-05	16	192	4	IPR011025
Domain	-	GNAL GNAT2 GNA14 GNAT3	1.79e-05	16	192	4	1.10.400.10
Domain	G-alpha	GNAL GNAT2 GNA14 GNAT3	1.79e-05	16	192	4	PF00503
Domain	G_alpha	GNAL GNAT2 GNA14 GNAT3	1.79e-05	16	192	4	SM00275
Domain	IQ	MYH3 MYO1A MYO5B MYO7A OBSCN IQGAP1 RNF32	1.99e-05	81	192	7	SM00015
Domain	Gprotein_alpha_su	GNAL GNAT2 GNA14 GNAT3	2.32e-05	17	192	4	IPR001019
Domain	IQ_motif_EF-hand-BS	MYH3 MYO1A MYO5B MYO7A OBSCN IQGAP1 RNF32	3.96e-05	90	192	7	IPR000048
Domain	IQ	MYH3 MYO1A MYO5B MYO7A OBSCN IQGAP1 RNF32	4.89e-05	93	192	7	PS50096
Domain	DHC_N1	DNAH10 DYNC2H1 DNAH11	5.77e-05	8	192	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH10 DYNC2H1 DNAH11	5.77e-05	8	192	3	IPR013594
Domain	Cytoplasmic_FMR1-int	CYFIP1 CYFIP2	1.05e-04	2	192	2	IPR008081
Domain	Hormone_4	AVP OXT	1.05e-04	2	192	2	PF00220
Domain	Hormone_5	AVP OXT	1.05e-04	2	192	2	PF00184
Domain	K_chnl_inward-rec_Kir2.2	KCNJ12 KCNJ18	1.05e-04	2	192	2	IPR003272
Domain	NEUROHYPOPHYS_HORM	AVP OXT	1.05e-04	2	192	2	PS00264
Domain	Neurhyp_horm	AVP OXT	1.05e-04	2	192	2	PD001676
Domain	Neurohypophysial_hormone_CS	AVP OXT	1.05e-04	2	192	2	IPR022423
Domain	FragX_IP	CYFIP1 CYFIP2	1.05e-04	2	192	2	PF05994
Domain	-	AVP OXT	1.05e-04	2	192	2	2.60.9.10
Domain	NH	AVP OXT	1.05e-04	2	192	2	SM00003
Domain	U2A'_phosphoprotein32A_C	ANP32E ANP32B ANP32A	1.66e-04	11	192	3	IPR003603
Domain	LRRcap	ANP32E ANP32B ANP32A	1.66e-04	11	192	3	SM00446
Domain	K_chnl_inward-rec_Kir_N	KCNJ12 KCNJ18	3.13e-04	3	192	2	IPR013673
Domain	IRK_N	KCNJ12 KCNJ18	3.13e-04	3	192	2	PF08466
Domain	Dynein_heavy_dom-2	DNAH10 DYNC2H1 DNAH11	3.58e-04	14	192	3	IPR013602
Domain	DHC_N2	DNAH10 DYNC2H1 DNAH11	3.58e-04	14	192	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH10 DYNC2H1 DNAH11	3.58e-04	14	192	3	IPR011704
Domain	AAA_5	DNAH10 DYNC2H1 DNAH11	3.58e-04	14	192	3	PF07728
Domain	Myosin_head_motor_dom	MYH3 MYO1A MYO5B MYO7A	6.08e-04	38	192	4	IPR001609
Domain	MYOSIN_MOTOR	MYH3 MYO1A MYO5B MYO7A	6.08e-04	38	192	4	PS51456
Domain	Myosin_head	MYH3 MYO1A MYO5B MYO7A	6.08e-04	38	192	4	PF00063
Domain	MYSc	MYH3 MYO1A MYO5B MYO7A	6.08e-04	38	192	4	SM00242
Domain	Neurhyp_horm	AVP OXT	6.22e-04	4	192	2	IPR000981
Domain	DUF1394	CYFIP1 CYFIP2	6.22e-04	4	192	2	IPR009828
Domain	DUF1394	CYFIP1 CYFIP2	6.22e-04	4	192	2	PF07159
Domain	ARM_REPEAT	ZER1 KPNA4 ODAD2 KIFAP3	7.41e-04	40	192	4	PS50176
Domain	ARM	ZER1 KPNA4 ODAD2 KIFAP3	7.41e-04	40	192	4	SM00185
Domain	BTB-kelch_protein	KLHL8 KBTBD2 KBTBD12 KLHL26	9.76e-04	43	192	4	IPR017096
Domain	FerI	OTOF MYOF	1.03e-03	5	192	2	SM01202
Domain	FerB	OTOF MYOF	1.03e-03	5	192	2	SM01201
Domain	Ferlin_B-domain	OTOF MYOF	1.03e-03	5	192	2	IPR012561
Domain	Ferlin_C	OTOF MYOF	1.03e-03	5	192	2	PF16165
Domain	Ferlin_C	OTOF MYOF	1.03e-03	5	192	2	IPR032362
Domain	FerIin_dom	OTOF MYOF	1.03e-03	5	192	2	IPR012968
Domain	FerI	OTOF MYOF	1.03e-03	5	192	2	PF08151
Domain	FerB	OTOF MYOF	1.03e-03	5	192	2	PF08150
Domain	Armadillo	ZER1 KPNA4 ODAD2 KIFAP3	1.37e-03	47	192	4	IPR000225
Domain	-	NLRP12 LRRTM4 ANP32E ZER1 ANP32B ECM2 NLRP6 FBXL16 TLR4 ANP32A	1.84e-03	321	192	10	3.80.10.10
Domain	ARM-like	CAND1 TAF7L ZER1 KPNA4 ODAD2 KIFAP3 HEATR9 CTNNBL1 TNPO3	1.96e-03	270	192	9	IPR011989
Domain	-	CAND1 ZER1 KPNA4 ODAD2 KIFAP3 HEATR9 CTNNBL1 TNPO3	2.14e-03	222	192	8	1.25.10.10
Domain	L_dom-like	NLRP12 LRRTM4 ANP32E ZER1 ANP32B ECM2 NLRP6 FBXL16 TLR4 ANP32A	2.16e-03	328	192	10	IPR032675
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	CAND1 MRPS27 MCM6 INTS3 TAF7L ANP32E TBPL2 ANP32B CAPN2 GTF2A1 POLR3B KHDRBS1 CSNK2B ANP32A	5.15e-08	390	195	14	17643375
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	MRPS27 MCM6 BIRC6 IQGAP1 CYFIP1 ANP32E SEC23B VCPIP1 KPNA4 FARSB DHX30 NBAS POLR3B KHDRBS1 WDHD1 SSU72 CTNNBL1	5.49e-07	704	195	17	29955894
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	BIRC6 ADCY6 NLN KLHL8 AKAP6 DOCK9 MYOF DNM3 ZNF286A NIN	6.42e-07	225	195	10	12168954
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CAND1 LIN7C MYO1A MARK1 MCM6 NDUFA10 IQGAP1 ATXN7L3 GNAL KLHL8 GPT2 VCPIP1 LAMB4 DYNC2H1 SIRT1 POLR3B SSU72 CSNK2B TNPO3 NIN	1.10e-06	1005	195	20	19615732
Pubmed	Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.	ANP32E ANP32B ANP32A	1.72e-06	5	195	3	21636789
Pubmed	The Anp32 family of proteins containing leucine-rich repeats.	ANP32E ANP32B ANP32A	1.72e-06	5	195	3	15895553
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	CAND1 FAM98B BIRC6 IQGAP1 SEC23B VCPIP1 KPNA4 NUP107 ANP32B FARSB ABCF2 PDCD2L SIRT1 PATJ	4.78e-06	571	195	14	37167062
Pubmed	BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.	MARK1 AK6 NCAPH2 AIF1L GPT2 RNF32 GXYLT1 GTF2A1 TFB1M SSU72 LSS RIOK2	4.93e-06	419	195	12	33001583
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CAND1 MRPS27 MCM6 FAM98B INTS3 BIRC6 IQGAP1 CYFIP1 ANP32E SEC23B VCPIP1 KPNA4 ANP32B CAPN2 PRSS56 FARSB ABCF2 PDCD2L DHX30 CSNK2B ANP32A CTNNBL1 RIOK2	5.07e-06	1415	195	23	28515276
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CAND1 MRPS27 MCM6 NDUFA10 IQGAP1 CYFIP1 ANP32E TDRD6 GNL3L NUP107 DNAH10 DYNC2H1 ANP32B FARSB ABCF2 PRDM7 CYFIP2 DHX30 PBRM1 KHDRBS1 CSNK2B ANP32A CTNNBL1	5.68e-06	1425	195	23	30948266
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CAND1 LIN7C MYO5B MCM6 NDUFA10 IQGAP1 BRAP CYFIP1 GPT2 KPNA4 NUP107 FARSB ABCF2 CYFIP2 DHX30 MYOF KHDRBS1 INF2 CSNK2B ANP32A PATJ	7.89e-06	1247	195	21	27684187
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYO7A OBSCN CBLC ARHGEF11 BIRC6 DUS1L KCNG1 NADK ZER1 DOCK9 STK32C REV3L DHX30 ORC1 MYOF INF2 SSU72 TNFAIP2 TNPO3	1.64e-05	1105	195	19	35748872
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CAND1 MCM6 FAM98B IQGAP1 S100A4 ANP32E ANP32B CAPN2 FARSB SIRT1 POLR3B PBRM1 KHDRBS1 WDHD1 SSU72 CSNK2B ANP32A CTNNBL1	1.82e-05	1014	195	18	32416067
Pubmed	A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels.	LIN7C KCNJ12 KCNJ18	2.02e-05	10	195	3	14960569
Pubmed	Abi1 is essential for the formation and activation of a WAVE2 signalling complex.	CYFIP1 CYFIP2 NIN	2.02e-05	10	195	3	15048123
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	CAND1 MCM6 COG3 BIRC6 IQGAP1 S100A4 CYFIP1 ANP32E COG5 SEC23B VCPIP1 KPNA4 ANP32B CAPN2 FARSB ABCF2 SIRT1 GTF2A1 WDHD1 CSNK2B ANP32A TNPO3	2.50e-05	1455	195	22	22863883
Pubmed	Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes.	ASAP1 APBB1IP CYFIP2 KHDRBS1	2.68e-05	31	195	4	19041431
Pubmed	Ferlin Overview: From Membrane to Cancer Biology.	OTOF MYOF	3.13e-05	2	195	2	31443490
Pubmed	The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line.	AVP OXT	3.13e-05	2	195	2	2991279
Pubmed	Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.	AVP OXT	3.13e-05	2	195	2	29609987
Pubmed	Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia.	CYFIP1 CYFIP2	3.13e-05	2	195	2	38128786
Pubmed	A systematic survey of the intergenic region between the murine oxytocin- and vasopressin-encoding genes.	AVP OXT	3.13e-05	2	195	2	8863731
Pubmed	Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage.	AVP OXT	3.13e-05	2	195	2	24412107
Pubmed	Synthesis, transport, and release of posterior pituitary hormones.	AVP OXT	3.13e-05	2	195	2	6153132
Pubmed	The contributions of oxytocin and vasopressin pathway genes to human behavior.	AVP OXT	3.13e-05	2	195	2	22245314
Pubmed	Mothers of autistic children: lower plasma levels of oxytocin and Arg-vasopressin and a higher level of testosterone.	AVP OXT	3.13e-05	2	195	2	24086383
Pubmed	Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase.	NOS2 TLR4	3.13e-05	2	195	2	11159012
Pubmed	Adenylyl cyclase 6 activation negatively regulates TLR4 signaling through lipid raft-mediated endocytosis.	ADCY6 TLR4	3.13e-05	2	195	2	24218452
Pubmed	Influence of perioperative stress on central and peripheral oxytocin and arginine-vasopressin concentrations.	AVP OXT	3.13e-05	2	195	2	31538678
Pubmed	Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree.	AVP OXT	3.13e-05	2	195	2	21899794
Pubmed	New Insights into the Anti-Inflammatory and Antioxidant Properties of Nitrated Phospholipids.	NOS2 TLR4	3.13e-05	2	195	2	29488638
Pubmed	Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis.	NLRP12 NLRP6	3.13e-05	2	195	2	24338634
Pubmed	Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes.	NOS2 TLR4	3.13e-05	2	195	2	19395279
Pubmed	Marital behavior, oxytocin, vasopressin, and wound healing.	AVP OXT	3.13e-05	2	195	2	20144509
Pubmed	Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse.	KCNJ12 KCNJ18	3.13e-05	2	195	2	15705530
Pubmed	Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro.	AVP OXT	3.13e-05	2	195	2	12944509
Pubmed	Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.	NOS2 TLR4	3.13e-05	2	195	2	19073249
Pubmed	Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism.	CYFIP1 CYFIP2	3.13e-05	2	195	2	29752658
Pubmed	Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder.	AVP OXT	3.13e-05	2	195	2	19500216
Pubmed	Defensive behavioral strategies and enhanced state anxiety during chronic subordinate colony housing are accompanied by reduced hypothalamic vasopressin, but not oxytocin, expression.	AVP OXT	3.13e-05	2	195	2	19120108
Pubmed	S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway.	S100A4 TLR4	3.13e-05	2	195	2	39241524
Pubmed	S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4-ERK1/2 Signaling.	S100A4 TLR4	3.13e-05	2	195	2	29556233
Pubmed	Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65.	NOS2 SIRT1	3.13e-05	2	195	2	25389371
Pubmed	An mDia1-INF2 formin activation cascade facilitated by IQGAP1 regulates stable microtubules in migrating cells.	IQGAP1 INF2	3.13e-05	2	195	2	27030671
Pubmed	Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus.	AVP OXT	3.13e-05	2	195	2	9678638
Pubmed	Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin.	AVP OXT	3.13e-05	2	195	2	21960250
Pubmed	Comparison of vasopressin and oxytocin expressions in the hypothalamo-neurohypophysial system of patients with chronic heart failure.	AVP OXT	3.13e-05	2	195	2	19672816
Pubmed	Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons.	AVP OXT	3.13e-05	2	195	2	22262306
Pubmed	The neurohypophyseal hormones vasopressin and oxytocin. Precursor structure, synthesis and regulation.	AVP OXT	3.13e-05	2	195	2	3768139
Pubmed	Expression of the vasopressin and oxytocin genes in human hypothalami.	AVP OXT	3.13e-05	2	195	2	4065330
Pubmed	Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling.	NOS2 CASP2	3.13e-05	2	195	2	24830635
Pubmed	Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways.	NOS2 TLR4	3.13e-05	2	195	2	15282190
Pubmed	EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1.	MECOM SIRT1	3.13e-05	2	195	2	21555002
Pubmed	Chromosomal mapping of two members of the human dynein gene family to chromosome regions 7p15 and 11q13 near the deafness loci DFNA 5 and DFNA 11.	DYNC2H1 DNAH11	3.13e-05	2	195	2	9325061
Pubmed	NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice.	NLRP6 TLR4	3.13e-05	2	195	2	36911699
Pubmed	C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response.	CYFIP1 CYFIP2	3.13e-05	2	195	2	24357318
Pubmed	Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions.	AVP OXT	3.13e-05	2	195	2	23589638
Pubmed	[Oxytocin and vasopressin: sexual differences and clinical implications].	AVP OXT	3.13e-05	2	195	2	37200960
Pubmed	SIRT1-related inhibition of pro-inflammatory responses and oxidative stress are involved in the mechanism of nonspecific low back pain relief after exercise through modulation of Toll-like receptor 4.	SIRT1 TLR4	3.13e-05	2	195	2	25922201
Pubmed	On the nature of oxytocin and vasopressin from human pituitary.	AVP OXT	3.13e-05	2	195	2	13591312
Pubmed	Fundamental Contribution and Host Range Determination of ANP32A and ANP32B in Influenza A Virus Polymerase Activity.	ANP32B ANP32A	3.13e-05	2	195	2	30996088
Pubmed	Species specific differences in use of ANP32 proteins by influenza A virus.	ANP32B ANP32A	3.13e-05	2	195	2	31159925
Pubmed	m-Calpain colocalizes with the calcium-sensing receptor (CaR) in caveolae in parathyroid cells and participates in degradation of the CaR.	CAPN2 CASR	3.13e-05	2	195	2	12783889
Pubmed	Medial amygdala lesions modify aggressive behavior and immediate early gene expression in oxytocin and vasopressin neurons during intermale exposure.	AVP OXT	3.13e-05	2	195	2	23403283
Pubmed	Expression of the arginine vasopressin gene in response to salt loading in oxytocin gene knockout mice.	AVP OXT	3.13e-05	2	195	2	14962074
Pubmed	Cytoplasmic FMR1 interacting protein (CYFIP) family members and their function in neural development and disorders.	CYFIP1 CYFIP2	3.13e-05	2	195	2	34327661
Pubmed	The tyrosine kinase Pyk2 regulates Arf1 activity by phosphorylation and inhibition of the Arf-GTPase-activating protein ASAP1.	ASAP1 PTK2B	3.13e-05	2	195	2	12771146
Pubmed	Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.	AVP OXT	3.13e-05	2	195	2	36113782
Pubmed	Protein interactome and cell-type expression analyses reveal that cytoplasmic FMR1-interacting protein 1 (CYFIP1), but not CYFIP2, associates with astrocytic focal adhesion.	CYFIP1 CYFIP2	3.13e-05	2	195	2	35567753
Pubmed	The Role of Oxytocin and Vasopressin in Drug-Induced Reward-Implications for Social and Non-Social Factors.	AVP OXT	3.13e-05	2	195	2	36979340
Pubmed	Cyfip1 Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on Cyfip2 Genetic Background, Parent-of Origin, and Sex.	CYFIP1 CYFIP2	3.13e-05	2	195	2	31324746
Pubmed	Identification of human neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins.	AVP OXT	3.13e-05	2	195	2	6574452
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CAND1 LIN7C MRPS27 AIF1L NDUFA10 ARHGEF11 IQGAP1 ATXN7L3 CYFIP1 KPNA4 GNL3L FARSB ABCF2 CYFIP2 DHX30 ORC1 MYOF PBRM1 TFB1M CTNNBL1 PATJ ZBTB11	3.83e-05	1497	195	22	31527615
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	MYO5B TBC1D5 GMEB2 ADCY6 ATXN7L3 KLHL8 MAGEB18 KIFAP3 EXOC5 CSNK2B ANP32A LTBP1 KLHL26	4.35e-05	608	195	13	16713569
Pubmed	Isoforms of mammalian adenylyl cyclase: multiplicities of signaling.	ADCY10 ADCY6 GNAL	6.04e-05	14	195	3	14993377
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH10 DYNC2H1 DNAH11	6.04e-05	14	195	3	9373155
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO1A MYO5B MYO7A	6.04e-05	14	195	3	8022818
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MCC MECOM ADCY6 ATXN7L3 AGO3 TAF7L GNL3L NUP107 PRSS56 PDCD2L REV3L SIRT1 SETDB2 PBRM1 CCNB3 CSNK2B CTNNBL1 NIN	6.30e-05	1116	195	18	31753913
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	ADCY10 CAND1 MRPS27 MCM6 FAM98B IQGAP1 SEC23B KPNA4 TBPL2 FARSB SIRT1 DHX30 KHDRBS1 TFB1M CSNK2B ANP32A CTNNBL1 CCT6B RIOK2 TNPO3	6.76e-05	1335	195	20	29229926
Pubmed	Mechanism of GTP hydrolysis by G-protein alpha subunits.	ADCY6 GNAL GNA14	7.51e-05	15	195	3	7937899
Pubmed	Cloning and characterization of the human phosphoinositide-specific phospholipase C-beta 1 (PLC beta 1).	GNAT2 GNA14 GNAT3	7.51e-05	15	195	3	11118617
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CAND1 MCM6 BIRC6 ASAP1 IQGAP1 CYFIP1 GNL3L NUP107 CAPN2 FARSB ABCF2 DHX30 ORC1 POLR3B TFB1M INF2 CSNK2B CTNNBL1 CCT6B RIOK2	8.11e-05	1353	195	20	29467282
Pubmed	Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.	HNF4G NFATC4 POC5 GNAT2 DNM3 LTBP1	9.24e-05	129	195	6	23563607
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	CAND1 LIN7C TBC1D5 AK6 MCM6 FAM98B INTS3 ASAP1 IQGAP1 BRAP NLN CYFIP1 ANP32E COG5 CAPN2 MYOF KHDRBS1 INF2 CSNK2B CTNNBL1	9.32e-05	1367	195	20	32687490
Pubmed	Plasma concentrations of peptide hormones: Unrealistic levels of vasopressin (AVP), oxytocin (OXT), and brain natriuretic peptide (BNP).	AVP OXT	9.35e-05	3	195	2	39034759
Pubmed	MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes.	NOS2 TLR4	9.35e-05	3	195	2	16648192
Pubmed	Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.	AVP OXT	9.35e-05	3	195	2	28715127
Pubmed	Gustducin couples fatty acid receptors to GLP-1 release in colon.	FFAR2 GNAT3	9.35e-05	3	195	2	23341498
Pubmed	The contribution of AKAP5 in amylase secretion from mouse parotid acini.	ADCY6 AKAP6	9.35e-05	3	195	2	20164376
Pubmed	Inflammasome-independent role of NLRP12 in suppressing colonic inflammation regulated by Blimp-1.	NLRP12 TLR4	9.35e-05	3	195	2	27105524
Pubmed	Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia.	SIRT1 TLR4	9.35e-05	3	195	2	30071285
Pubmed	The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers.	OTOF MYOF	9.35e-05	3	195	2	23859474
Pubmed	KPNA6 is a Cofactor of ANP32A/B in Supporting Influenza Virus Polymerase Activity.	ANP32B ANP32A	9.35e-05	3	195	2	35044222
Pubmed	Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation.	KCNJ12 KCNJ18	9.35e-05	3	195	2	10904001
Pubmed	Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.	ANP32B ANP32A	9.35e-05	3	195	2	12522243
Pubmed	NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans.	NOS2 TLR4	9.35e-05	3	195	2	19575238
Pubmed	Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells.	NFATC4 NOS2	9.35e-05	3	195	2	16475165
Pubmed	Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophages.	NOS2 TLR4	9.35e-05	3	195	2	20649597
Pubmed	Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission.	NOS2 TLR4	9.35e-05	3	195	2	22167804
Pubmed	Expression of TLR 2, TLR 4 and iNOS in cervical monocytes of Chlamydia trachomatis-infected women and their role in host immune response.	NOS2 TLR4	9.35e-05	3	195	2	21883620
GeneFamily	ANP32 acidic nuclear phosphoproteins	ANP32E ANP32B ANP32A	3.59e-06	5	130	3	27
GeneFamily	Dyneins, axonemal	DNAH14 DNAH10 DNAH11	2.29e-04	17	130	3	536
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	MECOM PRDM9 PRDM7	2.29e-04	17	130	3	1197
GeneFamily	Ferlin family	OTOF MYOF	7.55e-04	6	130	2	828
GeneFamily	Components of oligomeric golgi complex	COG3 COG5	1.40e-03	8	130	2	493
GeneFamily	MCM family	MCM6 MCMDC2	1.79e-03	9	130	2	1085
GeneFamily	PDZ domain containing\|Crumbs complex	LIN7C PATJ	1.79e-03	9	130	2	1223
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	MECOM PRDM9 SETDB2	1.85e-03	34	130	3	487
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY10 ADCY6	2.22e-03	10	130	2	53
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL8 KBTBD2 KBTBD12 ZBTB11 KLHL26	2.84e-03	134	130	5	861
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A IQGAP1 APBB1IP FNIP2 ANP32B FFAR2 MYOF TNFAIP2 LY75	1.40e-07	186	195	9	7950e03ea080238c168b9d807e217f459acdfb28
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 TBC1D5 PTK2B DOCK9 GXYLT1 DNM3 GNAT3 NIN	6.31e-07	163	195	8	7a04192710f55acf5a4681d5f09942358fdb02ff
ToppCell	367C-Fibroblasts-Fibroblast-F-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ADCY10 AIF1L KCNB2 OLFML1 KCNJ12 SFRP4 THBS3 KBTBD12	7.24e-07	166	195	8	1cc291a04f4144abba4aca7badeb7776db05d903
ToppCell	367C-Fibroblasts-Fibroblast-F\|367C / Donor, Lineage, Cell class and subclass (all cells)	ADCY10 AIF1L KCNB2 OLFML1 KCNJ12 SFRP4 THBS3 KBTBD12	7.24e-07	166	195	8	2887f4f0c218cbcbcc82eef27aa4ee714b35cddb
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCM6 APBB1IP ANP32B FFAR2 ORC1 WDHD1 TNFAIP2 LY75	1.13e-06	176	195	8	270d7908dbd84028958d257f94941dc685e20255
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A IQGAP1 FNIP2 ANP32B FFAR2 MYOF TNFAIP2 LY75	1.13e-06	176	195	8	b0b87eebcf5c994386b39ca607e17f10e9d9de74
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A IQGAP1 FNIP2 ANP32B FFAR2 MYOF TNFAIP2 LY75	1.17e-06	177	195	8	67cc3a6461db5e0678f96b18224aeb83ad34b0f4
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MECOM DNAH14 RNF32 DOCK9 FARSB MYOF CATSPERB PATJ	1.39e-06	181	195	8	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SOX18 KIRREL3 LMCD1 DOCK9 IFI44 GNA14 DNM3 LTBP1	1.51e-06	183	195	8	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EFHB FHAD1 AKAP6 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	1.64e-06	185	195	8	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Myeloid-B_(Activated_Macrophage)\|World / shred on cell class and cell subclass (v4)	IQGAP1 APBB1IP FNIP2 ANP32B FFAR2 MYOF TNFAIP2 LY75	1.70e-06	186	195	8	33d731a7883d75e4e7db83b641cdb1e9a39938bf
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARK1 EFHB KIRREL3 OAF ECM2 OXT TRIM67 GREB1	1.77e-06	187	195	8	8bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARK1 EFHB KIRREL3 OAF ECM2 OXT TRIM67 GREB1	1.77e-06	187	195	8	3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EFHB FHAD1 AKAP6 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.24e-06	193	195	8	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	FHAD1 AKAP6 CFAP47 DNAH10 DYNC2H1 ODAD2 GNA14 DNAH11	2.24e-06	193	195	8	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B MECOM AIF1L DNAH14 CASR ARHGAP6 CGNL1 PATJ	2.33e-06	194	195	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B MECOM DNAH14 CASR CYFIP2 ARHGAP6 CGNL1 PATJ	2.42e-06	195	195	8	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	MYO5B CFAP47 DNAH10 DYNC2H1 ODAD2 GNA14 PATJ DNAH11	2.52e-06	196	195	8	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	IQGAP1 TRANK1 NADK FFAR2 NLRP6 TLR4 TNFAIP2 NIN	2.92e-06	200	195	8	95c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell	367C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ADCY10 GCNT3 MYO5B AIF1L KCNB2 DNAH10 KBTBD12	7.16e-06	161	195	7	c61283c301a87bb802f6f8ce79c26067032dd7d9
ToppCell	367C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ADCY10 GCNT3 MYO5B AIF1L KCNB2 DNAH10 KBTBD12	7.16e-06	161	195	7	9864d8b0929dacf4be7a4e97d2527ac3120ea264
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	OBSCN ARHGEF11 BRAP KCNG1 AKAP6 OXT KLHL26	1.23e-05	175	195	7	69ed3c7c45df6bef70f5f2ff003531160bf3b32b
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A S100A4 APBB1IP ANP32B FFAR2 TLR4 TNFAIP2	1.28e-05	176	195	7	6548797336c9f4ca0f38e74a2c629e2a4defa252
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP12 GMIP S100A4 NLN APBB1IP GNL3L TNFAIP2	1.43e-05	179	195	7	61dbfc1b9b0344c06a68142c181cd62993556a67
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB SYNGAP1 FHAD1 DNAH10 DYNC2H1 ODAD2 DNAH11	1.43e-05	179	195	7	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BFSP1 ANP32E ANP32B CCDC57 MYOF TNFAIP2 LY75	1.59e-05	182	195	7	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IQGAP1 APBB1IP FNIP2 ANP32B MYOF TNFAIP2 LY75	1.71e-05	184	195	7	fe9ea4d0e0be820e95eaf9bb42a5560d0e177574
ToppCell	3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MCC SOX18 MECOM AIF1L KCNJ12 OTOA DOCK9	1.71e-05	184	195	7	842473fa415575441b595073a994b6d621169776
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	AIF1L OAF OLFML1 NFATC4 SFRP4 ECM2 LTBP1	1.77e-05	185	195	7	506eee2c1b6e8acec3aa8b2c66868010006c4c14
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO5B MCC GNAL HAPLN1 ARHGAP6 TRIM67 GREB1	1.83e-05	186	195	7	948815663c212c4311329d503b5991cbbbff9808
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	ABI3 NXT2 NADK ANP32E KPNA4 CASP2 TNFAIP2	1.83e-05	186	195	7	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	HNF4G BIRC6 TRANK1 GNL3L ARHGAP6 GTF2A1 PBRM1	1.83e-05	186	195	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	MARK1 KCNB2 LRRTM4 LMCD1 ECM2 ARHGAP6 LTBP1	1.89e-05	187	195	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	droplet-Kidney-nan-3m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC SOX18 S100A4 OTOA LMCD1 ECM2 DNM3	1.96e-05	188	195	7	67c04f446fa4528b13a381622e88eb1f314cc6d5
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCC SOX18 S100A4 OTOA LMCD1 ECM2 DNM3	1.96e-05	188	195	7	03a7f6538cfddc230c0eab10c3613929addd7e33
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IL13RA1 KIRREL3 ATP11C IFI44 HAPLN1 PDGFD LTBP1	1.96e-05	188	195	7	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO5B MCC GNAL HAPLN1 TRIM67 TNFAIP2 GREB1	2.03e-05	189	195	7	78cf414b98bcb19deb934409acddaad1cd51b67f
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	MCC MECOM AIF1L RND1 MYOF GNA14 LTBP1	2.24e-05	192	195	7	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARK1 AIF1L KCNJ12 LMCD1 ECM2 TRIM67 GREB1	2.24e-05	192	195	7	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 GNA14 DNAH11	2.32e-05	193	195	7	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX18 ASAP1 KCNJ12 LMCD1 TLR4 DNM3 LTBP1	2.32e-05	193	195	7	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B DNAH14 CASR CYFIP2 ARHGAP6 CGNL1 PATJ	2.32e-05	193	195	7	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 AKAP6 CFAP47 DNAH10 DYNC2H1 DNAH11	2.40e-05	194	195	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SOX18 ASAP1 NOS2 IFI44 GNA14 PDGFD DNM3	2.40e-05	194	195	7	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	MECOM CAPN2 CASR ARHGAP6 MYOF DNM3 CGNL1	2.56e-05	196	195	7	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.64e-05	197	195	7	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.64e-05	197	195	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	(4)_Endothelial_cells-(41)_EC-arteriolar\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	MCC MECOM AIF1L S100A4 LMCD1 PDGFD DNM3	2.64e-05	197	195	7	482e3f8926880afed88ed37553ed2b5ed58b8c99
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.64e-05	197	195	7	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.64e-05	197	195	7	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.64e-05	197	195	7	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.64e-05	197	195	7	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SOX18 MECOM AIF1L GNAT2 DOCK9 PDGFD CGNL1	2.82e-05	199	195	7	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	EFHB FHAD1 CFAP47 DNAH10 DYNC2H1 ODAD2 DNAH11	2.91e-05	200	195	7	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN ADCY6 ATXN7L3 KIRREL3 NFATC4 SFRP4 ECM2	2.91e-05	200	195	7	8a4c210a3130f7baedf15ecbc0f4903b97da0352
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GCNT3 STK32C ARHGAP6 HEATR9 DNM3 CATSPERB LTBP1	2.91e-05	200	195	7	326cae37cacd94b423a6ac8873ea56c5abaf0a0b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm\|5w / Sample Type, Dataset, Time_group, and Cell type.	MYH3 MYO7A CSRNP2 KCNJ12 HPS1 CASP2 LSS	2.91e-05	200	195	7	0927061536a664b4f7feb9e5b0a8c11ca0d5955c
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MARK1 VPS37D AKAP6 SFRP4 LMCD1 HEATR9	3.70e-05	141	195	6	7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OTOF TBPL2 GNL3L CYFIP2 ORC1 LY75	3.70e-05	141	195	6	9a0f4bee2893da1b13ab89494e6159821d53538b
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GMIP TRPM8 GNAT2 APBB1IP TRIM67 HEATR9	4.85e-05	148	195	6	003e10bf477984248211b99d75daa8f7dcdb12c8
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 LIN7C INTS3 KIRREL3 FNIP2 TNFAIP2	4.85e-05	148	195	6	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 LIN7C INTS3 KIRREL3 FNIP2 TNFAIP2	4.85e-05	148	195	6	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	MECOM CFAP47 DNAH10 ODAD2 PATJ DNAH11	5.43e-05	151	195	6	8216462e723fec2797387929dde095370947e10a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRTM4 PRRG4 ODAD2 HAPLN1 ARHGAP6 KBTBD12	6.05e-05	154	195	6	2d98bb7a784fc3215e0d4a1670d662e5df4716c3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRTM4 PRRG4 ODAD2 HAPLN1 ARHGAP6 KBTBD12	6.05e-05	154	195	6	0dec222101530f1727184dbb7c03969d3884f111
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CSRNP2 GNAL B3GALNT2 CASP2 PRDM7 KBTBD12	6.27e-05	155	195	6	d10cf5e922dbd3ca46660404da5aca43f181fc19
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MARK1 MCM6 OAF LMCD1 TRIM67 GREB1	8.01e-05	162	195	6	3f264263878af630921911c2b344ac56eb1e7099
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH3 DPY19L3 MYO5B OBSCN PTK2B NLRP6	8.01e-05	162	195	6	4d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH3 DPY19L3 OBSCN PTK2B NLRP6 INF2	8.29e-05	163	195	6	b0aa4a620bd58011225b42ea6dda04e3101ba342
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3 S100A4 PTK2B NADK CYFIP2 TNFAIP2	8.57e-05	164	195	6	15d52666e5150e7c34b1f641a937fb2d5e8aaf8a
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX18 MECOM IFI44 PDGFD CGNL1 LY75	8.57e-05	164	195	6	6a41a159134e605b80d5e731f9ed5bc803bb531b
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX18 MECOM IFI44 PDGFD CGNL1 LY75	8.57e-05	164	195	6	ec68954fc09b6850273b5e59caa6b09d02151097
ToppCell	facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3 S100A4 PTK2B NADK CYFIP2 TNFAIP2	8.57e-05	164	195	6	d622f0d8d8bad48dfdf160ec63c545df192637a9
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A S100A4 APBB1IP INF2 TLR4 TNFAIP2	8.86e-05	165	195	6	1dcd6b8aa192baeaa1f7bb334843edab6049b96f
ToppCell	facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GMIP S100A4 ATXN7L3 KIRREL3 SETDB2 TLR4	9.16e-05	166	195	6	5c132f505dc5f699c87913f140344fc9f8e7e0f5
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX18 MECOM IFI44 PDGFD CGNL1 LY75	9.16e-05	166	195	6	27af6c906cff1d40d134f0386db7708869691121
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 MCC GXYLT1 DNM3 GNAT3 NIN	9.47e-05	167	195	6	528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OBSCN KCNB2 OTOF KCNJ12 LMCD1 KBTBD12	9.47e-05	167	195	6	91b14df450bfb6a2b406c88f8c75cd51eeb9e82b
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 MCC GXYLT1 DNM3 GNAT3 NIN	9.47e-05	167	195	6	a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	APBB1IP ANP32B MYOF TLR4 TNFAIP2 LY75	9.79e-05	168	195	6	a1755afa2cc50960ba60e07d84d61be429cdea72
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 S100A4 PTK2B NADK CYFIP2 TNFAIP2	9.79e-05	168	195	6	c0aef5947b1d7e2c81a7481c509feda1687fcd7f
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 S100A4 PTK2B NADK CYFIP2 TNFAIP2	9.79e-05	168	195	6	c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCell	droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 PTK2B NADK APBB1IP KPNA4 CYFIP2	9.79e-05	168	195	6	d823979335ac6b5d1f062ebb741c759d2f919dbf
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 PTK2B NADK APBB1IP KPNA4 CYFIP2	9.79e-05	168	195	6	4b5be7c6662eceddf90a65015f12908278d1664e
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 PTK2B NADK APBB1IP KPNA4 CYFIP2	9.79e-05	168	195	6	689c41f6e9f65381570991cc311cba49a57ec955
ToppCell	droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 PTK2B NADK APBB1IP KPNA4 CYFIP2	9.79e-05	168	195	6	f377ff4c066a9857ad14d245e56325ad220e22e1
ToppCell	droplet-Lung-nan-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3 PTK2B NADK APBB1IP KPNA4 CYFIP2	1.01e-04	169	195	6	ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCell	droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3 PTK2B NADK APBB1IP KPNA4 CYFIP2	1.01e-04	169	195	6	c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 DNAH10 DYNC2H1 ODAD2 DNAH11	1.01e-04	169	195	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCNT3 MYO1A PTK2B KIRREL3 CYFIP1 DNM3	1.04e-04	170	195	6	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCNT3 MYO1A PTK2B KIRREL3 CYFIP1 DNM3	1.04e-04	170	195	6	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)\|Thalamus / BrainAtlas - Mouse McCarroll V32	ADCY10 MYO5B KCNG1 FFAR2	1.05e-04	56	195	4	cc072782b296e75e1bb11e62d280ca199b73481e
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)--\|Thalamus / BrainAtlas - Mouse McCarroll V32	ADCY10 MYO5B KCNG1 FFAR2	1.05e-04	56	195	4	0c137f6263626df9837e5c00fa6ba6201bfebf52
ToppCell	Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	ADCY10 MYO5B KCNG1 FFAR2	1.05e-04	56	195	4	435fdc82c2c078e5f37a60de36ce80ca0c3aade8
ToppCell	droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3 S100A4 PTK2B NADK APBB1IP CYFIP2	1.08e-04	171	195	6	00739085fdbc4d64c9faacba2c2adeab580dd2b1
ToppCell	facs-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MECOM AIF1L CASR CYFIP2 GREB1 CGNL1	1.11e-04	172	195	6	87a30a219b0a6979abb5fba292a2d8ea946fd849
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SOX18 DOCK9 HAPLN1 GNA14 INF2 LY75	1.11e-04	172	195	6	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	facs-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MECOM AIF1L CASR CYFIP2 GREB1 CGNL1	1.11e-04	172	195	6	5030ac31709cac236bb58f4ef9d545d24690411a
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A S100A4 APBB1IP ANP32B FFAR2 TNFAIP2	1.15e-04	173	195	6	279efbab7810fa60ab12ea5d09a84800df4adef0
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFHB FHAD1 DNAH10 DYNC2H1 ODAD2 DNAH11	1.15e-04	173	195	6	c3762655caa79ac4879876f470d32578a3c93b01
Drug	Methylatropine nitrate [52-88-0]; Up 200; 11uM; MCF7; HT_HG-U133A	MYO7A NFATC4 KCNG1 ZER1 LAMB4 ECM2 FFAR2 DOCK9 CASP2 GNA14 TLR4 LSS	1.34e-07	198	193	12	6495_UP
Drug	AC1L45X9	AVP BRAP OXT	6.00e-07	3	193	3	CID000151233
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	TBC1D5 MCC NXT2 BFSP1 ZER1 CASP2 ORC1 ARHGAP6 EXOC5 SERPIND1	5.14e-06	189	193	10	6717_DN
Drug	Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A	MCC NCAPH2 ADCY6 ZER1 VCPIP1 GNL3L CASP2 BCO1 KIFAP3 DNM3	6.47e-06	194	193	10	2825_UP
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MCC NCAPH2 NXT2 HPS1 NADK DYNC2H1 CASP2 EXOC5 GNA14 PATJ	7.09e-06	196	193	10	3206_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A	BFSP1 KCNG1 NADK ZER1 ABCF2 MYOF GTF2A1 GNA14 TNFAIP2 GREB1	7.09e-06	196	193	10	2291_DN
Drug	atractylenolide I	NOS2 OXT TLR4	2.05e-05	7	193	3	CID005321018
Drug	NaCl	NLRP12 AVP ADCY6 S100A4 PTK2B NLN KCNG1 FGF1 NOS2 LAMB4 CAPN2 REV3L HAPLN1 OXT CSNK2B TNFAIP2	2.68e-05	564	193	16	CID000005234
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A	TBC1D5 MCC ST7L HPS1 GNAL LAMB4 ECM2 IFI44 LSS	3.53e-05	189	193	9	6895_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	KCNG1 ZER1 PRRG4 GNL3L LMCD1 DOCK9 CAPN2 CASP2 LSS	3.68e-05	190	193	9	4582_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A	ZER1 PRRG4 GNL3L CASP2 KHDRBS1 DNM3 CCT6B LSS PATJ	4.16e-05	193	193	9	3814_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A	TBC1D5 NCAPH2 ADCY6 NADK SFRP4 GTF2A1 CCT6B LSS PATJ	4.51e-05	195	193	9	6235_UP
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A	MYO7A KCNG1 SFRP4 CASP2 HAPLN1 KIFAP3 MYOF PDGFD GREB1	4.69e-05	196	193	9	1497_UP
Drug	Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A	IL13RA1 CAND1 NCAPH2 ANP32E SEC23B PGS1 KIFAP3 KHDRBS1 WDHD1	4.69e-05	196	193	9	1790_DN
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	MCC ADCY6 KCNG1 HPS1 ARHGAP6 GTF2A1 INF2 CCT6B PATJ	4.88e-05	197	193	9	4532_DN
Drug	Methantheline bromide [53-46-3]; Up 200; 9.6uM; PC3; HT_HG-U133A	KCNG1 FGF1 LMCD1 ECM2 CCDC57 TLR4 DNM3 CCT6B PATJ	4.88e-05	197	193	9	5780_UP
Drug	Pivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	GCNT3 MARK1 PTK2B EXD3 FGF1 SFRP4 DOCK9 CCDC57 THBS3	4.88e-05	197	193	9	5046_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A	IL13RA1 LIN7C TBC1D5 NXT2 CASP2 EXOC5 THBS3 TLR4 TNFAIP2	4.88e-05	197	193	9	1311_DN
Drug	HNMPA-(AM)3; Down 200; 5uM; PC3; HG-U133A	LIN7C NFATC4 HPS1 FGF1 SEC23B CASP2 HAPLN1 GNA14 KLHL26	4.88e-05	197	193	9	583_DN
Drug	Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	LIN7C ARHGEF11 KCNG1 TRPM8 NKAIN1 LAMB4 BCO1 MYOF THBS3	5.08e-05	198	193	9	7451_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	NCAPH2 NXT2 EXD3 PRRG4 GNL3L CASP2 ABCF2 MYOF PATJ	5.08e-05	198	193	9	2303_DN
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A	NCAPH2 S100A4 EXD3 HPS1 PRRG4 DYNC2H1 THBS3 CCT6B PATJ	5.08e-05	198	193	9	3553_DN
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MCC BFSP1 PRRG4 VCPIP1 GNL3L DOCK9 CASP2 ABCF2 LSS	5.28e-05	199	193	9	2273_DN
Drug	NH-P	HPS1 CASR OXT CSNK2B CTNNBL1	7.11e-05	51	193	5	CID000001702
Drug	AC1NURZQ	AVP OXT	7.15e-05	2	193	2	CID005490952
Drug	2-phenylalanine	AVP OXT	7.15e-05	2	193	2	CID000031722
Drug	Cgp 29325	AVP OXT	7.15e-05	2	193	2	CID000175772
Drug	Glumitocin	AVP OXT	7.15e-05	2	193	2	CID003084054
Drug	Demoxytocin	AVP OXT	7.15e-05	2	193	2	CID000008229
Drug	P9-28	AVP OXT	7.15e-05	2	193	2	CID000139428
Drug	Pro-arg-gly-amide	AVP OXT	7.15e-05	2	193	2	CID000170777
Drug	Phasvatocin	AVP OXT	7.15e-05	2	193	2	CID000192334
Drug	ethyl cyclohexylideneacetate	AVP OXT	7.15e-05	2	193	2	CID000073776
Disease	Dysmenorrhea	AVP OXT	4.08e-05	2	189	2	C0013390
Disease	thrombopoietin receptor measurement	NLRP12 DPY19L3	1.22e-04	3	189	2	EFO_0020769
Disease	chromosome 15q11.2 deletion syndrome (implicated_via_orthology)	CYFIP1 CYFIP2	1.22e-04	3	189	2	DOID:0060393 (implicated_via_orthology)
Disease	NAD kinase measurement	NLRP12 NADK	1.22e-04	3	189	2	EFO_0801821
Disease	Hyponatremia	AVP OXT	2.43e-04	4	189	2	C0020625
Disease	protein S100-A4 measurement	NLRP12 S100A4	2.43e-04	4	189	2	EFO_0021893
Disease	Lung Injury	SIRT1 PDGFD TLR4	3.16e-04	21	189	3	C0273115
Disease	Chronic Lung Injury	SIRT1 PDGFD TLR4	3.16e-04	21	189	3	C2350344
Disease	interleukin 1 receptor antagonist measurement	NLRP12 TRANK1 AKAP6 DNAH11	3.74e-04	53	189	4	EFO_0004754
Disease	programmed cell death protein 5 measurement	NLRP12 DPY19L3	4.03e-04	5	189	2	EFO_0801927
Disease	AP-4 complex subunit mu-1 measurement	NLRP12 PBRM1	4.03e-04	5	189	2	EFO_0801385
Disease	Polyuria	AVP OXT	4.03e-04	5	189	2	C0032617
Disease	hearing impairment	MYO1A MYO7A OTOF OTOA TLR4	4.29e-04	98	189	5	C1384666
Disease	obesity (implicated_via_orthology)	TBC1D5 GNL3L DNAH10 CAPN2 SIRT1 GNA14 TLR4	4.93e-04	215	189	7	DOID:9970 (implicated_via_orthology)
Disease	oxytocin-neurophysin 1 measurement	AVP OXT	6.02e-04	6	189	2	EFO_0802839
Disease	diabetic angiopathy (implicated_via_orthology)	PTK2B NOS2	6.02e-04	6	189	2	DOID:11713 (implicated_via_orthology)
Disease	blood urea nitrogen measurement	MECOM MCM6 NKAIN1 VPS37D DOCK9 GXYLT1 CCDC57 SIRT1 THBS3 LY75	7.12e-04	452	189	10	EFO_0004741
Disease	Ischemia	AVP S100A4 OXT	7.53e-04	28	189	3	C0022116
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	OTOF MYOF	8.39e-04	7	189	2	DOID:11724 (implicated_via_orthology)
Disease	Microcephaly	GPT2 FARSB ORC1 LSS	9.12e-04	67	189	4	C0025958
Disease	McCune Albright syndrome (implicated_via_orthology)	GNAT2 GNAT3	1.11e-03	8	189	2	DOID:1858 (implicated_via_orthology)
Disease	Intestinal Diseases	MYO5B NOS2	1.11e-03	8	189	2	C0021831
Disease	age at initiation of corrective lens use	TBC1D5 POLR3B	1.11e-03	8	189	2	EFO_0021781
Disease	anterior uveitis	TBC1D5 NOS2 KIFAP3	1.12e-03	32	189	3	EFO_1000811
Disease	body weight	IL13RA1 DPY19L3 CBLC MECOM KCNB2 HNF4G ADCY6 DNAH14 BRAP NFATC4 NADK POC5 GNAT2 AKAP6 NBAS DNM3 LTBP1 PATJ	1.30e-03	1261	189	18	EFO_0004338
Disease	behavioural disinhibition measurement	KIRREL3 GNAL TRIM67 DNAH11	1.39e-03	75	189	4	EFO_0006946
Disease	hip circumference	LIN7C MCM6 KIRREL3 POC5 GNAT2 DNAH10 CCT6B PATJ	1.58e-03	338	189	8	EFO_0005093
Disease	Colorectal Carcinoma	OBSCN MCC KCNB2 ATP11C AKAP6 SFRP4 STK32C HAPLN1 CCNB3 PDGFD TLR4 ANP32A	1.99e-03	702	189	12	C0009402
Disease	serum IgG glycosylation measurement	ABI3 NXPE1 LRRTM4 DNAH10 IFI44 ABCF2 CYFIP2 GTF2A1 GNA14 TLR4	2.11e-03	523	189	10	EFO_0005193
Disease	Moyamoya disease	NLN DOCK9 DNM3	2.15e-03	40	189	3	MONDO_0016820
Disease	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	KCNB2 DNAH11	2.16e-03	11	189	2	EFO_0009923
Disease	trans/cis-18:2 fatty acid measurement, trans fatty acid measurement	NLN FGF1	2.16e-03	11	189	2	EFO_0006821, EFO_0006825
Disease	liver fibrosis measurement	BRAP KLHL8 NLRP6 DNM3	2.30e-03	86	189	4	EFO_0010576
Disease	insomnia measurement	KCNB2 EXD3 LRRTM4 NADK COG5 PBRM1 TLR4 CCT6B DNAH11	2.33e-03	443	189	9	EFO_0007876
Disease	volumetric bone mineral density	PTK2B FHAD1 SFRP4	2.47e-03	42	189	3	EFO_0007620
Disease	Intellectual Disability	MCC SYNGAP1 GPT2 AKAP6 CASP2 FARSB POLR3B LSS ZBTB11	2.47e-03	447	189	9	C3714756
Disease	collagen disease (implicated_via_orthology)	TLR4 DNM3	2.58e-03	12	189	2	DOID:854 (implicated_via_orthology)
Disease	obsolete_red blood cell distribution width	DPY19L3 MYO1A TBC1D5 MECOM MCM6 NCAPH2 ST7L BIRC6 IQGAP1 CYFIP1 ATP11C COG5 SEC23B PGS1 ANP32B FFAR2 KBTBD2 PBRM1	2.66e-03	1347	189	18	EFO_0005192
Disease	Uterine leiomyoma	PGBD2 NUP107 DNM3 GREB1	2.82e-03	91	189	4	HP_0000131
Disease	candidiasis (implicated_via_orthology)	ANP32E ANP32B ANP32A	2.82e-03	44	189	3	DOID:1508 (implicated_via_orthology)
Disease	lung disease (implicated_via_orthology)	NOS2 TLR4	3.04e-03	13	189	2	DOID:850 (implicated_via_orthology)
Disease	platelet crit	TBC1D5 MECOM ST7L ARHGEF11 BRAP PRRG4 KLHL8 PGBD2 PGS1 LMCD1 ANP32B FBXL16 LY75 TNPO3	3.43e-03	952	189	14	EFO_0007985
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	CBLC MCM6 KCNB2 BIRC6 POC5 VPS37D DNAH11	3.51e-03	303	189	7	EFO_0004612, EFO_0020945
Disease	Kartagener syndrome (implicated_via_orthology)	ODAD2 DNAH11	3.53e-03	14	189	2	DOID:0050144 (implicated_via_orthology)
Disease	glutamine measurement	NFATC4 VPS37D KPNA4 PBRM1	3.55e-03	97	189	4	EFO_0009768
Disease	myocardial infarction (biomarker_via_orthology)	NOS2 CASR SIRT1 CSNK2B PDGFD	3.77e-03	160	189	5	DOID:5844 (biomarker_via_orthology)
Disease	Fibrosis	SIRT1 PDGFD TLR4	4.06e-03	50	189	3	C0016059
Disease	Cirrhosis	SIRT1 PDGFD TLR4	4.06e-03	50	189	3	C1623038
Disease	Acute kidney injury	AVP NOS2 SIRT1 TLR4	4.11e-03	101	189	4	C2609414
Disease	Acute Kidney Insufficiency	AVP NOS2 SIRT1 TLR4	4.11e-03	101	189	4	C1565662
Disease	Kidney Failure, Acute	AVP NOS2 SIRT1 TLR4	4.11e-03	101	189	4	C0022660
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	GMIP ZER1 PGS1 DNAH11	4.25e-03	102	189	4	EFO_0004329, EFO_0004611
Disease	Weight Gain	IQGAP1 FGF1 OXT DNAH11	4.25e-03	102	189	4	C0043094
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A OTOF OTOA	4.30e-03	51	189	3	cv:CN043650
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	MECOM BRAP DYNC2H1	4.54e-03	52	189	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	red blood cell density measurement	MECOM ARHGEF11 HNF4G KCNJ12 KLHL8 PGBD2 DNAH10 ANP32B THBS3 PBRM1 DNM3 CGNL1 LY75	4.57e-03	880	189	13	EFO_0007978
Disease	isocitrate measurement	LRRTM4 TRPM8	4.62e-03	16	189	2	EFO_0010505
Disease	anthranilic acid measurement	COG5 PDGFD	4.62e-03	16	189	2	EFO_0010460
Disease	chronotype measurement	TBC1D5 KCNB2 HNF4G BIRC6 SYNGAP1 KIRREL3 EXD3 LRRTM4 ANP32E SHCBP1L KBTBD2 WDHD1 PATJ	4.66e-03	882	189	13	EFO_0008328
Disease	risky sexual behaviour measurement	HNF4G BIRC6 LRRTM4 C4orf33 STK32C	4.75e-03	169	189	5	EFO_0007877
Disease	Hypotension	AVP FGF1 OXT	4.79e-03	53	189	3	C0020649
Disease	mean corpuscular hemoglobin concentration	DPY19L3 MECOM BRAP KCNJ12 VPS37D PGS1 ANP32B FFAR2 KBTBD2 NLRP6 GTF2A1 THBS3 GNA14 WDHD1 LY75	5.18e-03	1105	189	15	EFO_0004528
Disease	low density lipoprotein cholesterol measurement, body fat percentage	MCM6 DNAH10	5.21e-03	17	189	2	EFO_0004611, EFO_0007800
Disease	Necrotizing Enterocolitis	NOS2 TLR4	5.21e-03	17	189	2	C0520459
Disease	matrix metalloproteinase 12 measurement	DYNC2H1 PDGFD	5.84e-03	18	189	2	EFO_0010590
Disease	Idiopathic hypogonadotropic hypogonadism	FGF17 POLR3B	5.84e-03	18	189	2	C0342384
Disease	Tourette syndrome, schizophrenia	TBC1D5 DNAH10	5.84e-03	18	189	2	EFO_0004895, MONDO_0005090
Disease	mean platelet volume	TBC1D5 MECOM ST7L ASAP1 TRANK1 KLHL8 VPS37D CASR NLRP6 DNM3 CATSPERB LTBP1 LY75 NIN	6.23e-03	1020	189	14	EFO_0004584
Disease	immature platelet fraction	TBC1D5 ST7L ASAP1 DNM3	6.29e-03	114	189	4	EFO_0009187
Disease	physical activity measurement, body mass index	HNF4G POC5 GNAT2 AKAP6	6.29e-03	114	189	4	EFO_0004340, EFO_0008002

Protein segments in the cluster

Peptide	Gene	Start	Entry
SVYDSNLEAALECEN	ZNF286A	146	Q9HBT8
REFLCDQKYSDEENL	AIF1L	31	Q9BQI0
LDAIQVNYYLDEENC	GPT2	226	Q8TD30
CIYNNLEFGIDLDTR	ABCF2	411	Q9UG63
FNSIEDDVCQLVYVE	BRAP	226	Q7Z569
FLNDITEQYLEVELC	C4orf33	66	Q8N1A6
EDSRVFSAYQDCIQL	BIRC6	1966	Q9NR09
FCNLIEEFQIYVDEA	CATSPERB	1036	Q9H7T0
YCSEVLAILLQDNDE	CTNNBL1	261	Q8WYA6
FLTYDEVQERLQACR	CBLC	241	Q9ULV8
FYVELEANNEGVECL	ADCY6	991	O43306
SVRSYTLCEFAQEQE	CSRNP2	101	Q9H175
YRNQELEDEIIFITC	CASR	751	P41180
RDLACFIQFENVNIY	APBB1IP	351	Q7Z5R6
AREELQQVAAQFCSY	ARHGEF11	821	O15085
YNFDQDTLEICSKEQ	DNAH11	4061	Q96DT5
EVFVQAALLAQDYCD	DUS1L	86	Q6P1R4
AALLAQDYCDAIDLN	DUS1L	91	Q6P1R4
FNCEVTNLNDYRENV	ANP32A	121	P39687
FNCEVTNLNDYRESV	ANP32B	121	Q92688
FNCEITNLEDYRESI	ANP32E	121	Q9BTT0
ATRDFDANLYLCEEA	DPY19L3	386	Q6ZPD9
DDNCFTADELQLLTY	AGO3	771	Q9H9G7
FEECLEFIHQYENNR	ADCY10	1396	Q96PN6
ASAQCNEYSEEEELV	DHX30	1001	Q7L2E3
QEIYADLVEDSCLGF	ATXN7L3	21	Q14CW9
NSPRVDDFVYICDDN	CCNB3	1221	Q8WWL7
DCVFTEIVLENNYTA	FGF17	126	O60258
QYARDLAALEQQCDE	GMEB2	311	Q9UKD1
LTNIEEENCQRYLDE	IQGAP1	486	P46940
VSEREANDALNAYVC	INTS3	66	Q68E01
FDLVEEYENICGSQV	NUP107	171	P57740
NDQELDCDILQLEYV	SERPIND1	336	P05546
NLAFEDATENECREF	KIAA1107	901	Q9UPP5
QCEIFQVLYEEATAS	AK6	121	Q9Y3D8
ERQYRCEDCDQLFES	MECOM	206	Q03112
LLRVADYCEDNYVQA	ABI3	26	Q9P2A4
RDFCDVQRYNILEEV	NOS2	381	P35228
VCFYNDLELLDATVA	OTOA	346	Q7RTW8
ELLADIVNLCVDYYE	CYFIP1	236	Q7L576
ARAEEVCIQISNDYE	POC5	306	Q8NA72
LVDECNEVTDYAIAR	MCM6	536	Q14566
ENDILLCESRYNESD	PBRM1	1251	Q86U86
EITCYENFTDNQLDV	FFAR2	161	O15552
IQACFERASEYQLND	GNAT3	136	A8MTJ3
ADILYEDQQCLVFRD	HINT2	66	Q9BX68
VLQSEFCNAVREVYE	LIN7C	41	Q9NUP9
SCYEEALRDEEQRTQ	MAGEB18	301	Q96M61
EEYLEQRDLYLTQCQ	MCMDC2	646	Q4G0Z9
CYENELAFLSRDEED	KCNJ12	376	Q14500
VFQDCRNLDFLDLGY	LRRTM4	176	Q86VH4
VQYNQNRFLCDDVDF	GREB1	1731	Q4ZG55
ILEDNSFEQFVINYC	MYO1A	386	Q9UBC5
EAEALYQACVREANA	GMIP	266	Q9P107
DTERLYSVVFQEICN	PUDP	21	Q08623
VDDDELREYCIQAFE	CAND1	266	Q86VP6
YRFLELACDSQEDVD	DNM3	606	Q9UQ16
DEDLLDKFCTELYQQ	IFNA1;	101	P01562
EDYDDISNQIDFIIC	NADK	166	O95544
LEEAENDICRYDFVE	PDGFD	101	Q9GZP0
NDICRYDFVEVEDIS	PDGFD	106	Q9GZP0
LDDNTCFNDVERYDI	KLHL8	421	Q9P2G9
DRFLNSFEELQAEEC	LTBP1	1611	Q14766
CVADEDDYRDFVNLD	PDCD2L	191	Q9BRP1
QDRYVFLQDCAEIAD	PGS1	246	Q32NB8
QLIYESVIACEYLDD	GSTO2	81	Q9H4Y5
VYEALRNCSFEDDNI	GXYLT1	381	Q4G148
EDFESCEERRYLQSA	LSS	631	P48449
VEQLYETACFLQVED	KBTBD2	101	Q8IY47
NEFQQDYDIRDCAAV	LY75	741	O60449
TNFDDILNVCDDYDV	KCNG1	96	Q9UIX4
YNLSQVREADCRAFI	MSLNL	121	Q96KJ4
ELLADIVNICVDYYE	CYFIP2	236	Q96F07
LYDEIEAEVNLCFDQ	CYFIP2	711	Q96F07
DIADIENEENRYCLF	NBAS	2146	A2RRP1
QIDDNEYACLKAIVF	HNF4G	231	Q14541
IEQKQRELADYLCED	INF2	886	Q27J81
YLCEDAQQLSLEDTF	INF2	896	Q27J81
CDEIIFAEDYQRVED	LMCD1	311	Q9NZU5
QNFISRCLFYEVEVN	IL13RA1	251	P78552
RCLFYEVEVNNSQTE	IL13RA1	256	P78552
EKCEVLQYSAREAQD	NDUFA10	251	O95299
YIQYLREADECIESE	OLFML1	101	Q6UWY5
YQLIDCAQYFLERID	GNAL	156	P38405
VRNVSADDDAVYICE	OBSCN	391	Q5VST9
RLQEVAFYQLQQDCD	ARHGAP6	226	O43182
CARDDEEQNLVAFQY	PRDM9	321	Q9NQV7
CREQEFQDIYNFVES	ORC1	506	Q13415
VRELLQDGCYSDFLN	COG5	56	Q9UP83
ELQELANAERSGECY	DYNC2H1	3736	Q8NCM8
CQEGAYLRNDIFEDA	EXOC5	236	O00471
RLALQYSEQCIEAYE	MCC	446	P23508
LIEYNEAECSFVLQD	FHAD1	41	B1AJZ9
ISIQDYEVFRCEDSL	IFI44	141	Q8TCB0
ESLLEVCDDYNLNEN	KCNB2	71	Q92953
AYSAEVTLDLDCVQD	KLHL26	121	Q53HC5
QDLQLDYSLTDEFCR	DOCK9	1096	Q9BZ29
EFEAVLTERQNIYCS	CCDC127	161	Q96BQ5
ANSLYRFLLDDQECA	CGNL1	306	Q0VF96
RDYLSGFQEQCDAIL	COG3	131	Q96JB2
EFDLNEIRLIVYQDC	FNIP2	41	Q9P278
DDDCYIDLEAVFNRI	B3GALNT2	356	Q8NCR0
DEFRSKYENECECQL	BFSP1	121	Q12934
VDDNALQCLEEYLRY	GCNT3	416	O95395
RCLQEDFVYNLQVLE	CCDC57	51	Q2TAC2
YDCQADNDDELTFIE	ASAP1	1076	Q9ULH1
LRGNEFFCEVDEDYI	CSNK2B	16	P67870
QLERINDALSCEYEC	FAM98B	206	Q52LJ0
YSLDEFCEEQLQQAT	DNAH14	351	Q0VDD8
YLENNQIEEITEICF	ECM2	491	O94769
DANNCDYEQKERFLL	MARK1	726	Q9P0L2
LLDQLFDYCDVDNDG	EFHB	601	Q8N7U6
DDICQEQFLELSYLN	KHDRBS1	261	Q07666
RAELQDDAVYECQAI	KIRREL3	116	Q8IZU9
DDAVYECQAIQAAIR	KIRREL3	121	Q8IZU9
LCEDYRTDENRLNEE	LAMB4	1531	A4D0S4
VFEQLACEAARLAQY	H2BK1	66	A0A2R8Y619
GFANIDQETYRCELI	PTK2B	256	Q14289
YSRLREQEQCFAVEA	HPS1	156	Q92902
ADDQLIIDFDNFVRC	CAPN2	651	P17655
CQDLSDVLQILEEFY	DNAH10	471	Q8IVF4
YEEDTDQDQALSCLD	CFAP47	2501	Q6ZTR5
YIEALAQVFSERACD	CASP2	386	P42575
YETQEDAFVRQALCR	NLRP6	626	P59044
QQEDDEFVCQIIYVF	KIFAP3	601	Q92845
YSRVLENCEDVADFD	OTOF	31	Q9HC10
QELQADAARLCAFYA	PRSS56	356	P0CW18
SNAELCEYLDDRDQE	NXPE1	226	Q8N323
CLDQDAVIASFDQLY	HAPLN1	181	P10915
ECNQREVILYDITAE	KBTBD12	66	Q3ZCT8
VDQACRAAEEFVNIY	NXT2	11	Q9NPJ8
VSDLDICEFIDNYAL	FBXL16	176	Q8N461
VALSEYDQVLAECDN	GNA14	226	O95837
TCEAEDIATYEQNLQ	MRPS27	366	Q92552
DCSEEYLERQLQAEF	TAF7L	361	Q5H9L4
CYENELAFLSRDEED	KCNJ18	376	B7U540
EDAFILICNVSLEYE	CCT6B	226	Q92526
NICEDYLVSVRLVDF	TDRD6	1591	O60522
AFDILAENCEFRENE	DNTT	171	P04053
LYEDVSRENDCLQEE	NIN	1251	Q8N4C6
LYAACDEVESELNEA	NFATC4	191	Q14934
VFENYTACLETEEQR	RND1	46	Q92730
LQECASEENYRAAIK	ODAD2	656	Q5T2S8
ESYCQDVLRRQEEFE	GNL3L	86	Q9NVN8
FVGTAEALRCQEENY	OXT	66	P01178
VQACFERAAEYQLND	GNAT2	136	P19087
EECLFLERLEENHYN	FGF1	96	P05230
CARDDEEQNLVAFQY	PRDM7	321	Q9NQW5
ILCSYNTNIEELFAE	RNF32	236	Q9H0A6
ESCENYTALIEERIN	SHCBP1L	271	Q9BZQ2
YKVDCEAVRGDIFNQ	SIRT1	376	Q96EB6
RDNEVDFQEYCVFLS	S100A4	66	P26447
CDEDPQLFAYNFREE	TFB1M	311	Q8WVM0
FEIFEYNSLEQLCIN	MYH3	466	P11055
CFYLEVGQLSQDRDF	NKAIN1	81	Q4KMZ8
VCAEAVDAIYTRQED	OAF	161	Q86UD1
EYCENQFTVEAAEVV	FARSB	276	Q9NSD9
FLYVVDTCLEEDDLQ	SEC23B	131	Q15437
YLQDCLDAIQQDFVI	STK32C	421	Q86UX6
AEVQLCYLEAQRDAV	AKAP6	911	Q13023
NAYEEDGCIVFDVIA	BCO1	311	Q9HAY6
GEYLEELDQICISFD	NCAPH2	31	Q6IBW4
EAYIAQRFCDNRIVS	ATP11C	36	Q8NB49
CQDAQVDLLAFRRYI	PGBD2	506	Q6P3X8
EEVTYENCLQALADV	NLN	81	Q9BYT8
QELFDTENVVVCQYD	GTF2A1	326	P52655
YEACLVAQCDALVDA	TRIM67	386	Q6ZTA4
NVEEVFRYLLETECN	SETDB2	201	Q96T68
LAAVAQFELCERDTY	TNFAIP2	261	Q03169
NQFCDVTLLIEGEEY	ZBTB11	211	O95625
VNEYVELVNAACNFE	ZER1	51	Q7Z7L7
QQSVDTREKLYECFD	ZSCAN30	291	Q86W11
DVACEDLELYVSRNN	REV3L	1831	O60673
GEFIRALYESEENCE	SYNGAP1	511	Q96PV0
NEYCLDNTSLAEAVE	PATJ	741	Q8NI35
RCYNDEQDNAIDVEF	WDHD1	456	O75717
YEELVDVNCSAVLRF	SFRP4	61	Q6FHJ7
REDEQFYAAQALGCL	HEATR9	161	A2RTY3
FVGTAEALRCQEENY	AVP	66	P01185
CLAAVTYVDEDENEI	TTMP	86	Q5BVD1
LNNDCATAYVLLAEE	ST7L	231	Q8TDW4
EYLDVNEENDCNIAL	POLR3B	631	Q9NW08
EELCNYEEAREIFVD	PRRG4	71	Q9BZD6
EQSDTILLDCRNFYE	TSTD2	301	Q5T7W7
YQELREVAENCADKL	VPS37D	86	Q86XT2
NLQYRCNDTVPEDFE	THBS3	931	P49746
VYNASEDRLELCVDA	VCPIP1	951	Q96JH7
EVYGSENESERNCLE	RIOK2	346	Q9BVS4
LQIRQDVESCYFAAQ	TNPO3	51	Q9Y5L0
DVDLTEFDQYLNCSR	SOX18	321	P35713
EYLNDEEQFCKNVES	ZFAND1	251	Q8TCF1
NSVYDSNLEAALECE	ZNF286B	146	P0CG31
LTDVLFCYARENEQL	TBC1D5	186	Q92609
DEDLAEQLLVYSCEA	TRPM8	636	Q7Z2W7
DAFRCFEQIQEFDLA	TRANK1	1811	O15050
YLDDIIDLFNCLTNV	TLR4	296	O00206
CEERVYDQVVEDLNS	SSU72	111	Q9NP77
EETYLELYLDQCAAQ	TBPL2	36	Q6SJ96
ICEDSDIDGDYRVQN	KPNA4	56	O00629
CLYEIQEEEFIQQAL	NLRP12	616	P59046
ADGDNSYCLEAIIRQ	MYO5B	1646	Q9ULV0
EEQVIYAAADAYCLL	EXD3	546	Q8N9H8
LQYEARTFENLDACE	MYO7A	331	Q13402
YNCELENVAEFEGLT	MYOF	1481	Q9NZM1